Drugs / Angiogenic Cell Precursors
last change Jul 2009 re-read 3 minutes ago

Angiogenic Cell Precursors

also known as ACPs · Vescell TM

Cell therapy

Developed for
congestive heart failure · limb ischemia
Investigated by
TheraVitae Ltd.

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00523224 Jan 2006 → Sep 2007 congestive heart failure TheraVitae Ltd. Unknown No outcome recorded
Comparator or background therapy1 trial
Phase 2 NCT01584986 Comparator May 2008 → Apr 2009 limb ischemia Salus Ltd. Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as angiogenic cell precursors “Peripheral blood-derived, ex vivo expanded autologous angiogenic cell precursors (ACPs)” NCT01584986 ↗
1

“Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗

Known as ACPs “Peripheral blood-derived, ex vivo expanded autologous angiogenic cell precursors (ACPs)” NCT01584986 ↗
1

“Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗

Known as Vescell TM “Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗
Modality Cell therapy “Stem cells type Angiogenic Cell Precusors(ACPs)” NCT00523224 ↗
Route Intramuscular “injected into the ischemic gastrocnemius muscle” NCT01584986 ↗